Dr. Reddy’s Eschews M&As In Quest To Be Lead Generics Maker In 2013
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy’s Laboratories, which has largely eschewed large acquisitions, nonetheless expects to make its mark on the global market, becoming India’s largest maker of generics drugs by surpassing Ranbaxy Laboratories next year.